Teladoc Health (TDOC) Research & Development (2014 - 2026)

Teladoc Health has disclosed Research & Development across 13 years of filings, most recently posting $67.9 million for Q1 2026.

• Research & Development for Q1 2026 came in at $67.9 million, down 2.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $275.8 million (down 6.77% YoY), and the FY2025 annual result was $277.9 million, down 9.55% from the prior year.
• Research & Development came in at $67.9 million for Q1 2026 at Teladoc Health, down from $71.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $89.9 million in Q4 2023 to a low of $67.6 million in Q3 2025.
• The 5-year median for Research & Development is $78.7 million (2022), against an average of $78.5 million.
• Across the five-year window, Research & Development grew 13.81% in 2022 and slipped 14.66% in 2024, its largest moves.
• Teladoc Health's Research & Development stood at $82.9 million in 2022, then grew by 8.45% to $89.9 million in 2023, then decreased by 14.66% to $76.8 million in 2024, then dropped by 6.7% to $71.6 million in 2025, then dropped by 5.23% to $67.9 million in 2026.
• The last three Research & Development figures came in at $67.9 million (Q1 2026), $71.6 million (Q4 2025), and $67.6 million (Q3 2025), per Business Quant data.